We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2010 by Rambam Health Care Campus.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01248598
First Posted: November 25, 2010
Last Update Posted: November 25, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Rambam Health Care Campus
  Purpose
The purpose of this study is to study the prevalence of EBV, HCMV, HHV-6 in saliva and on the toothbrush patient with periodontitis.

Condition
Cytomegalovirus Epstein-Barr Virus Infections Herpesvirus Infection

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional

Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:
  • The Prevelance Rate of the EBV, HCMV, HHV-6 in saliva [ Time Frame: 1 year ]
    Check the EBV, HCMV, HHV-6 in saliva by PCR


Secondary Outcome Measures:
  • change outcomes EBV, HCMV, HHV-6 in saliva before and after toothbrushing [ Time Frame: 1 year ]
    Check the EBV, HCMV, HHV-6 in saliva by RC-PCR before and after toothbrushing


Estimated Enrollment: 10
Study Start Date: October 2010
Detailed Description:
Human cytomegalovirus (HCMV), Epstein-Barr virus (EBV) Human Herpes virus6 (HHV-6)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient of the Department of Periodontology, School of Graduate Dentistry Rambam Health care campus
Criteria

Inclusion Criteria:

  • Patient with peridontitis

Exclusion Criteria:

  • Previous periodontal treatment in last 3 month
  • Toothbrushing disability
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01248598


Locations
Israel
Department of Periodontology, School of Graduate Dentistry Rambam Health care campus Recruiting
Haifa, Israel
Contact: Dr. Leon Bilder    0544598769    leonid.bilder@mail.huji.ac.il   
Principal Investigator: Leon Bilder, DMD         
Sub-Investigator: Eli Machtei, DMD         
Sponsors and Collaborators
Rambam Health Care Campus
  More Information

Responsible Party: Department of Periodontology, School of Gradute Dentistry Rambam Health care campus Haifa, Israel
ClinicalTrials.gov Identifier: NCT01248598     History of Changes
Other Study ID Numbers: 400-10-RMB CTIL
First Submitted: November 21, 2010
First Posted: November 25, 2010
Last Update Posted: November 25, 2010
Last Verified: October 2010

Additional relevant MeSH terms:
Infection
Communicable Diseases
Virus Diseases
Epstein-Barr Virus Infections
Herpesviridae Infections
DNA Virus Infections
Tumor Virus Infections